Amedisys Inc. (AMED) Reports Q4 Adj-EPS of 95c; Guides FY11
Amedisys Inc. (NASDAQ: AMED) reported Q4 EPS of $0.95, $0.05 better than ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
